Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
/in Dendritic Cells, International Publications, Prostate Cancer, Urothelial Carcinoma /von 2021-06-09 / Vaccines (Basel) 2021 Jun;9(6)A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors.
/in Dendritic Cells, International Publications /von 2021-06-04 / J Clin Oncol 39, 2021 (suppl 15; abstr e14512)Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2021-06-04 / Cancers (Basel) 2021 Jun;13(11)Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
/in Dendritic Cells, International Publications /von 2021-05-20 / Cancers (Basel) 2021 May;13(10)CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2021-05-19 / Mol Ther Oncolytics 2021 Sep;22:64-71Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials
/in Dendritic Cells, International Publications, Malignant Melanoma, Malignant Pleural Mesothelioma /von 2021-05-19 / Vaccines (Basel) 2021 May;9(5)Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2021-05-14 / Ther Apher Dial 2021 Aug;25(4):415-424Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-05-12 / Cancer Med 2021 Jul;10(13):4302-4311Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2021-05-10 / Front Oncol 2021;11:672508
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de